AbbVie’s tavapadon holds potential to become prominent treatment in dopamine agonist market:…
Tavapadon’s profile and efficacy could redefine its role in Parkinson’s treatment, but market positioning remains a challenge,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
dopamine
GE Healthcare announces first patient dosed in phase-III clinical trial for new dopamine transporter…
Next-stage clinical study also proceeding for SPECT radiopharma